×
About 4,626 results

ALLMedicine™ Bacterial Vaginosis Center

Research & Reviews  2,111 results

Probiotics for preventing recurrent bacterial vaginosis.
https://doi.org/10.1097/01.JAA.0000731484.81301.58
JAAPA : Official Journal of the American Academy of Physician Assistants; Webb L

Jan 15th, 2021 - Multiple studies have shown that oral or vaginal probiotics can effectively treat and prevent recurrent bacterial vaginosis. The dose, route, and treatment protocols vary greatly between studies, but many have shown a statistically significant red...

Treatment of Male Sexual Partners of Women with Bacterial Vaginosis (BV); A Randomized,...
https://doi.org/10.1093/cid/ciaa1903
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America; Schwebke JR, Lensing SY et. al.

Dec 31st, 2020 - We aimed to determine if treatment of male sexual partners of women with recurrent BV with oral metronidazole twice daily for 7 days (i.e. multi-dose metronidazole) significantly decreased BV recurrence rates in the female. This was a multi-center...

Influence of intramuscular depot-medroxyprogesterone acetate initiation on vaginal micr...
https://doi.org/10.1093/cid/ciaa1876
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America; Whitney BM, Srinivasan S et. al.

Dec 23rd, 2020 - The vaginal microbiome plays a key role in women's reproductive health. Use of exogenous hormones, such as intramuscular depot-medroxyprogesterone acetate (DMPA-IM), may alter the composition of vaginal bacterial community. Vaginal swabs were coll...

Vaginal bacteria and risk of incident and persistent infection with high risk sub-types...
https://doi.org/10.1097/OLQ.0000000000001343
Sexually Transmitted Diseases; Carter KA, Srinivasan S et. al.

Dec 21st, 2020 - Bacterial vaginosis (BV) is associated with increased risk of high-risk HPV (hrHPV), whereas Lactobacillus-dominated vaginal microbiotas are associated with reduced burden of hrHPV. Few epidemiologic studies have prospectively investigated the rel...

Nucleic Acid Amplification Testing Compared With Cultures, Gram Stain, and Microscopy i...
https://doi.org/10.1097/LGT.0000000000000576
Journal of Lower Genital Tract Disease; Danby CS, Althouse AD et. al.

Dec 21st, 2020 - The aim of the study was to evaluate the performance of nucleic acid amplification testing (NAAT) for the diagnosis of vulvovaginal candidiasis (VVC), bacterial vaginosis, and Trichomonas vaginalis. A cross-sectional analysis of women with (n = 20...

see more →

Guidelines  13 results

Screening for Bacterial Vaginosis in Pregnant Persons to Prevent Preterm Delivery: US P...
https://doi.org/10.1001/jama.2020.2684
JAMA , Owens DK et. al.

Apr 7th, 2020 - Bacterial vaginosis is common and is caused by a disruption of the microbiological environment in the lower genital tract. In the US, reported prevalence of bacterial vaginosis among pregnant women ranges from 5.8% to 19.3% and is higher in some r...

No. 211-Screening and Management of Bacterial Vaginosis in Pregnancy.
https://doi.org/10.1016/j.jogc.2017.04.018
Journal of ObstEtrics and Gynaecology Canada : JOGC = Journal D'obstEtrique Et Gynecologie Du Canada : JOGC; Yudin MH, Money DM

Jul 21st, 2017 - To review the evidence and provide recommendations on screening for and management of bacterial vaginosis in pregnancy. The clinical practice options considered in formulating the guideline. Outcomes evaluated include antibiotic treatment efficacy...

Vulvovaginitis: screening for and management of trichomoniasis, vulvovaginal candidiasi...
https://doi.org/10.1016/S1701-2163(15)30316-9
Journal of ObstEtrics and Gynaecology Canada : JOGC = Journal D'obstEtrique Et Gynecologie Du Canada : JOGC; van Schalkwyk J, Yudin MH et. al.

May 23rd, 2015 - To review the evidence and provide recommendations on screening for and management of vulvovaginal candidiasis, trichomoniasis, and bacterial vaginosis. OUTCOMES evaluated include the efficacy of antibiotic treatment, cure rates for simple and com...

see more →

Drugs  75 results see all →

Clinicaltrials.gov  2,263 results

Probiotics for preventing recurrent bacterial vaginosis.
https://doi.org/10.1097/01.JAA.0000731484.81301.58
JAAPA : Official Journal of the American Academy of Physician Assistants; Webb L

Jan 15th, 2021 - Multiple studies have shown that oral or vaginal probiotics can effectively treat and prevent recurrent bacterial vaginosis. The dose, route, and treatment protocols vary greatly between studies, but many have shown a statistically significant red...

Solosec - secnidazole granule-Lupin Pharmaceuticals, Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=551e43d5-f700-4d6e-8029-026f8a8932ff

Jan 7th, 2021 - SOLOSEC® is a nitroimidazole antimicrobial indicated for the treatment of bacterial vaginosis in adult women. (1) To reduce the development of drug-resistant bacteria and maintain the effectiveness of SOLOSEC and other antibacterial drugs, SOLOSEC...

Treatment of Male Sexual Partners of Women with Bacterial Vaginosis (BV); A Randomized,...
https://doi.org/10.1093/cid/ciaa1903
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America; Schwebke JR, Lensing SY et. al.

Dec 31st, 2020 - We aimed to determine if treatment of male sexual partners of women with recurrent BV with oral metronidazole twice daily for 7 days (i.e. multi-dose metronidazole) significantly decreased BV recurrence rates in the female. This was a multi-center...

Vaginal Microbiota Can Affect HIV PrEP Drug Metabolism
https://www.medscape.com/viewarticle/943221

Dec 28th, 2020 - NEW YORK (Reuters Health) - Vaginal microbes associated with bacterial vaginosis (BV) metabolize drugs used in HIV pre-exposure prophylaxis (PrEP) at different rates, which could explain why PrEP is less effective in women than in men, new finding...

Influence of intramuscular depot-medroxyprogesterone acetate initiation on vaginal micr...
https://doi.org/10.1093/cid/ciaa1876
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America; Whitney BM, Srinivasan S et. al.

Dec 23rd, 2020 - The vaginal microbiome plays a key role in women's reproductive health. Use of exogenous hormones, such as intramuscular depot-medroxyprogesterone acetate (DMPA-IM), may alter the composition of vaginal bacterial community. Vaginal swabs were coll...

see more →

News  147 results

Vaginal Microbiota Can Affect HIV PrEP Drug Metabolism
https://www.medscape.com/viewarticle/943221

Dec 28th, 2020 - NEW YORK (Reuters Health) - Vaginal microbes associated with bacterial vaginosis (BV) metabolize drugs used in HIV pre-exposure prophylaxis (PrEP) at different rates, which could explain why PrEP is less effective in women than in men, new finding...

Consider Switching Up Treatment Regimens for Recurrent Bacterial Vaginosis
https://www.staging.medscape.com/viewarticle/938232

Sep 28th, 2020 - Limited data are available to guide treatment of recurrent bacterial vaginosis, but behavioral changes and switching between approved medication regimens may help, according to a presenter at the virtual conference on diseases of the vulva and vag...

Consider Switching Up Treatment Regimens for Recurrent Bacterial Vaginosis
https://www.medscape.com/viewarticle/938232

Sep 28th, 2020 - Limited data are available to guide treatment of recurrent bacterial vaginosis, but behavioral changes and switching between approved medication regimens may help, according to a presenter at the virtual conference on diseases of the vulva and vag...

Vaginal artesunate quells CIN 2/3 lesions, clears HPV
https://www.mdedge.com/obgyn/article/219749/gynecologic-cancer/vaginal-artesunate-quells-cin-2/3-lesions-clears-hpv/page/0/1?channel=53

Mar 29th, 2020 - Safety and next steps The safety analysis showed that side effects were generally mild and well tolerated. There were 161 adverse events among 29 women for whom safety data were available.

Jury Still Out on BV Screening in Pregnancy for At-Risk Women
https://www.medpagetoday.com/obgyn/pregnancy/82631

Oct 8th, 2019 - Insufficient evidence exists to recommend routine screening for pregnant women at higher risk of preterm birth for bacterial vaginosis, the U.S. Preventive Services Task Force (USPSTF) said. There was not enough evidence to determine the benefits ...

see more →

Patient Education  17 results see all →